Neurotech is proud to support our local community and Bryant University's 28th Annual Women's Summit. The Summit has a long tradition of empowering, supporting and encouraging women to excel professionally, personally, and financially. Neurotech was well represented at the event.
As part of our continued commitment to the Macular Telangiectasia (MacTel) Type 2 community, we would like to share this resource to learn more about this disease. How it is diagnosed, and how to meet its challenges. #mactel#retina#ophthalmology
https://t.co/YKRnOZ2Yif
Rich Small, Neurotech CEO announced that we have created an annual award in honor of our great colleague and friend Scott Hunter. The Scott βThe Jetβ Hunter Memorial award will be given to the Neurotech employee that demonstrates the admirable attributes that Scott was known for.
As part of our continued commitment to the MacTel Type 2 community, click this link https://t.co/lrmSETsgyR to learn about the disease, how it is diagnosed, and how to meet its challenges in a simple, user-friendly experience. #mactel#retina#ophthalmology#raredisease
This holiday season Neurotech employees are supporting the Woonsocket Adopt-A-Family-Program and the Globe Santa, a program of the Boston Globe Foundation. Thank you to our team members who joined together to make the wishes of these families come true during this time of giving.
Today, Neurotech Pharmaceuticals, Inc. honors the heroes who have bravely served our country. We are grateful for your sacrifices and unwavering dedication. Thank you for protecting our freedom. We truly value you. #neurotech#Veterans
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel). The prescription drug user fee act (PDUFA) goal date has been extended to March 18, 2025.
Learn more:
https://t.co/RdgwRo6hKR #mactel#retina
Neurotech employees give back to the local community by volunteering for one of the world's largest efforts for our ocean. Through partnership with the Save the Bay International Coastal Cleanup, we made an impact on the health of our local waters. #givingback#culture#neurotech
Are you living with Macular Telangiectasia Type 2 (MacTel) or have a family member who has been diagnosed with MacTel?
Join Prevent Blindness for on Thursday, November 14th from 6-7pm ET!
Register today: https://t.co/dWJNB3Hj2S
Are you living with Macular Telangiectasia Type 2 (MacTel) or have a family member who has been diagnosed with MacTel?
Join @PBA_savingsight for this 60-minute community forum on Thursday, November 14th from 6-7ET!
You will learn about MacTel (what it is, how it is diagnosed, and how it is managed), understand the patient experience of individuals living with MacTel, and learn about resources available to those living with MacTel.
For more information, visit: https://t.co/uZh6Zjb7Ux.
Today is World Sight Day. Letβs raise awareness about vision health and support efforts to prevent blindness and improve eye care worldwide.
Follow the link to learn about the importance of eye health and to access valuable resources: https://t.co/mMwQZP9gyR
#WorldSightDay
Visit the Neurotech Medical Affairs booth (#2051) at the American Academy of Ophthalmology (AAO) Annual meeting in Chicago from October 19-21. Meet our Medical Affairs team to learn more about Macular Telangiectasia Type 2. #mactel#retina#ophthalmology#eyecare
Attending the @aao_ophth Annual Congress in Chicago this year? Don't miss this opportunity to hear from these leading Retina Specialists. Doctor's Roger Goldberg, Emily Chew, Charlie Wykoff, David Lally, and Thomas Albini will be presenting clinical data related to MacTel.
Visit the Neurotech Medical Affairs booth (#2051) at the American Academy of Ophthalmology (AAO) Annual meeting in Chicago from October 19-21. Meet our Medical Affairs team to learn more about Macular Telangiectasia Type 2. #mactel#retina#ophthalmology#eyecare
We will see you in Barcelona at the 24th Euretina Congress from 19-22 September. Clinical data on MacTel will be presented by Dr. David R. Lally, Dr. Catherine Egan, and Dr. Baruch Kupperman.
Neurotech Pharmaceuticals, Inc. is a proud sponsor of the Ophthalmology Futures European and Retina Forums, 2024. During the View From the Top session yesterday, Jim Mazzo, Neurotech's Executive Chairman led the discussion with this esteemed panel of experts . #retina#mactel
Neurotech Pharmaceuticals, Inc. is attending the The Retina Society 57th Annual Scientific Meeting in Lisbon, Portugal from September 11-15. Don't miss the Scientific Sessions on Thursday, September 12th #retina#mactel#encapsulatedcelltherapy#ophthalmology